Literature DB >> 20947504

Docking-dependent ubiquitination of the interferon regulatory factor-1 tumor suppressor protein by the ubiquitin ligase CHIP.

Vikram Narayan1, Emmanuelle Pion, Vivien Landré, Petr Müller, Kathryn L Ball.   

Abstract

Characteristically for a regulatory protein, the IRF-1 tumor suppressor turns over rapidly with a half-life of between 20-40 min. This allows IRF-1 to reach new steady state protein levels swiftly in response to changing environmental conditions. Whereas CHIP (C terminus of Hsc70-interacting protein), appears to chaperone IRF-1 in unstressed cells, formation of a stable IRF-1·CHIP complex is seen under specific stress conditions. Complex formation, in heat- or heavy metal-treated cells, is accompanied by a decrease in IRF-1 steady state levels and an increase in IRF-1 ubiquitination. CHIP binds directly to an intrinsically disordered domain in the central region of IRF-1 (residues 106-140), and this site is sufficient to form a stable complex with CHIP in cells and to compete in trans with full-length IRF-1, leading to a reduction in its ubiquitination. The study reveals a complex relationship between CHIP and IRF-1 and highlights the role that direct binding or "docking" of CHIP to its substrate(s) can play in its mechanism of action as an E3 ligase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947504      PMCID: PMC3013021          DOI: 10.1074/jbc.M110.153122

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway.

Authors:  Jessica Pamment; Eleanor Ramsay; Michael Kelleher; David Dornan; Kathryn L Ball
Journal:  Oncogene       Date:  2002-11-07       Impact factor: 9.867

2.  Interferon-gamma-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production.

Authors:  M Flodström; D L Eizirik
Journal:  Endocrinology       Date:  1997-07       Impact factor: 4.736

3.  Allelotype of adenoma and differentiated adenocarcinoma of the stomach.

Authors:  G Tamura; K Sakata; S Nishizuka; C Maesawa; Y Suzuki; M Terashima; Y Eda; R Satodate
Journal:  J Pathol       Date:  1996-12       Impact factor: 7.996

4.  Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function.

Authors:  Yien Che Tsai; Paul S Fishman; Nitish V Thakor; George A Oyler
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

5.  Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.

Authors:  C L Willman; C E Sever; M G Pallavicini; H Harada; N Tanaka; M L Slovak; H Yamamoto; K Harada; T C Meeker; A F List
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

6.  A ubiquitin mutant with specific defects in DNA repair and multiubiquitination.

Authors:  J Spence; S Sadis; A L Haas; D Finley
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

7.  Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage.

Authors:  N Tanaka; M Ishihara; M S Lamphier; H Nozawa; T Matsuyama; T W Mak; S Aizawa; T Tokino; M Oren; T Taniguchi
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

8.  Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways.

Authors:  T Fujita; L F Reis; N Watanabe; Y Kimura; T Taniguchi; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Activation of IFN-beta element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis.

Authors:  N Watanabe; J Sakakibara; A G Hovanessian; T Taniguchi; T Fujita
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

10.  Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements.

Authors:  T Fujita; J Sakakibara; Y Sudo; M Miyamoto; Y Kimura; T Taniguchi
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

View more
  31 in total

1.  The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation.

Authors:  Syed Feroj Ahmed; Satamita Deb; Indranil Paul; Anirban Chatterjee; Tapashi Mandal; Uttara Chatterjee; Mrinal K Ghosh
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

Review 2.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

3.  Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/β-catenin signaling in colorectal cancer cells.

Authors:  Tomoyuki Ohsugi; Kiyoshi Yamaguchi; Chi Zhu; Tsuneo Ikenoue; Kiyoko Takane; Masaru Shinozaki; Giichiro Tsurita; Hideaki Yano; Yoichi Furukawa
Journal:  Oncogene       Date:  2019-07-10       Impact factor: 9.867

Review 4.  The essential functions of mitochondrial dynamics in immune cells.

Authors:  Jia-Huan Xie; Yi-Yuan Li; Jin Jin
Journal:  Cell Mol Immunol       Date:  2020-06-10       Impact factor: 11.530

5.  A multiprotein binding interface in an intrinsically disordered region of the tumor suppressor protein interferon regulatory factor-1.

Authors:  Vikram Narayan; Petr Halada; Lenka Hernychová; Yuh Ping Chong; Jitka Žáková; Ted R Hupp; Borivoj Vojtesek; Kathryn L Ball
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

6.  CHIP-dependent regulation of the actin cytoskeleton is linked to neuronal cell membrane integrity.

Authors:  Catarina Dias; Erisa Nita; Jakub Faktor; Ailish C Tynan; Lenka Hernychova; Borivoj Vojtesek; Jesper Nylandsted; Ted R Hupp; Tilo Kunath; Kathryn L Ball
Journal:  iScience       Date:  2021-07-17

7.  Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor Efficacy.

Authors:  Jiyong Liang; Lulu Wang; Chao Wang; Jianfeng Shen; Bojin Su; Anantha L Marisetty; Dexing Fang; Cynthia Kassab; Kang Jin Jeong; Wei Zhao; Yiling Lu; Abhinav K Jain; Zhicheng Zhou; Han Liang; Shao-Cong Sun; Changming Lu; Zhi-Xiang Xu; Qinghua Yu; Shan Shao; XiaoHua Chen; Meng Gao; Francois X Claret; Zhiyong Ding; Jian Chen; Pingsheng Chen; Michelle C Barton; Guang Peng; Gordon B Mills; Amy B Heimberger
Journal:  Cancer Immunol Res       Date:  2020-04-07       Impact factor: 11.151

8.  Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer.

Authors:  Pengfei Zhang; Chaonan Li; Hongchang Li; Lin Yuan; Hongmiao Dai; Zhiqiang Peng; Zhikang Deng; Zhijie Chang; Chun-Ping Cui; Lingqiang Zhang
Journal:  Cell Death Differ       Date:  2020-06-01       Impact factor: 15.828

Review 9.  Diverse roles of C-terminal Hsp70-interacting protein (CHIP) in tumorigenesis.

Authors:  Chao Sun; Hai-Long Li; Mei-Lin Shi; Qing-Hua Liu; Jin Bai; Jun-Nian Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-27       Impact factor: 4.553

10.  The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer.

Authors:  J L Schwartz; A N Shajahan; R Clarke
Journal:  Int J Breast Cancer       Date:  2011-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.